Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

Name: Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
Published: 2025
License: Public Domain

David S Shulman, MD · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

sarcoma, sarcoma, ewing, desmoplastic small round cell tumor, refractory sarcoma, osteosarcoma, rhabdomyosarcoma, relapsed sarcoma, interventional, phase1, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

Related documents